GLP1R and type 2 diabetes mellitus: The pharmacological armamentarium for the treatment and intervention of T2DM includes a range of oral hypoglycemic agents such as sodium-glucose transport protein 2 (SGLT2) inhibitors, biguanides, thiazolidinediones, and GLP-1 receptor agonists, as well as insulin [65,66,67].